Stereotaxis, Inc. cites 500 peer-reviewed publications on robotic electrophysiology safety and efficacy

Stereotaxis, Inc. cites 500 peer-reviewed publications on robotic electrophysiology safety and efficacy
Stereotaxis touts 500 studies

Stereotaxis, Inc. announced that over 500 peer-reviewed publications have validated the safety, efficacy, and efficiency of its robotic electrophysiology solutions.

The company encouraged interested parties to review the amassed clinical data, signaling continued confidence in the scientific foundation underpinning its robotic technology in electrophysiology procedures.

Stereotaxis previously launched a hiring campaign for roles focused on healthcare innovation. The company has also promoted its RoboticEP technology as a tool to address physician burnout and improve patient care. These initiatives reflect ongoing efforts to expand the adoption and impact of its robotics platform in clinical settings.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.